Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Dragonfly Therapeutics
Pfizer
ViroMissile, Inc.
Pfizer
AstraZeneca
Pfizer
Tizona Therapeutics, Inc
Dana-Farber Cancer Institute
Adaptimmune
AgonOx, Inc.
Novartis
OncoNano Medicine, Inc.
Calico Life Sciences LLC
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
AbbVie
Pfizer
Nurix Therapeutics, Inc.
JS InnoPharm, LLC
Incyte Corporation
Exelixis
Coherus Oncology, Inc.
Medical College of Wisconsin
DEKA Biosciences
AbbVie
Thomas Jefferson University
Scholar Rock, Inc.
Revolution Medicines, Inc.
University of California, San Diego
Tvardi Therapeutics, Incorporated
Poseida Therapeutics, Inc.
Immatics US, Inc.
Checkpoint Therapeutics, Inc.
Carisma Therapeutics Inc
Astellas Pharma Inc
Astellas Pharma Inc
BlueSky Immunotherapies GmbH
R-Pharm
Apexigen America, Inc.
Centre Georges Francois Leclerc
Oncorus, Inc.
Seagen Inc.
AbbVie
Quadriga Biosciences, Inc.
University Hospital, Ghent
Amgen
Revolution Medicines, Inc.
Imperial College London
Genocea Biosciences, Inc.